Ends copays for generic drugs for low-income Medicare Part D users starting in 2026.
This bill would end copayments for generic prescription drugs for low-income individuals enrolled in Medicare Part D, starting in 2026. It would also set copayments for other drugs at a 2023 level, adjusted yearly for inflation. This means many seniors and people with disabilities would pay less out-of-pocket for their medications.
Today, low-income individuals in Medicare Part D pay up to $1 for generic drugs and up to $3 for other drugs, or sometimes less depending on their plan. If this bill becomes law, starting in 2026, these individuals would pay $0 for generic drugs. For other drugs, their copayment would be set at the 2023 dollar amount, adjusted annually for inflation.
HR 4139 · 119th Congress · June 25, 2025 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers
1 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.